IFN-γ may also induce the expression of multiple immune checkpoint ligands, including programmed death-ligand 1 (PD-L1) and PD-L2 on tumor cells, and, therefore, attenuates the anti-tumor response mediated by T cells and NK cells [125,126]. This evidence concerns the gene IFNG and neoplasm.